Zhang, Shuyang

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine

COVID-19 Clinical Research StudiesSystemic Lupus Erythematosus Research

Cited by 2,179

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Zhang, W., Zhao, Y., Zhang, F., Wang, Q., Li, T., Liu, Z., Wang, J., Qin, Y., Zhang, X., Yan, X., et al. (2020) · Clinical Immunology

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 1,266

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 323

Establishment of Human Pluripotent Stem Cell‐Derived Skin Organoids Enabled Pathophysiological Model of SARS‐CoV‐2 Infection

Ma, J., liu, J., Gao, D., Li, X., Zhang, Q., Lv, L., Wang, Y., Li, J., Zhu, Y., Wu, Z., et al. (2022) · Advanced Science

Dermatological and COVID-19 studiesHair Growth and Disorders

Cited by 53

Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy

Ma, J., Li, W., Cao, R., Gao, D., Zhang, Q., Li, X., Li, B., Lv, L., Li, M., Jiang, J., et al. (2022) · Advanced Science

Systemic Sclerosis and Related DiseasesPluripotent Stem Cells Research

Cited by 38